Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells
Zhao, F.; Inague, A.; Peters-Clarke, T. M.; Chen, Y.; Ganjave, S. D.; Zhang, Y.; Miao, K.; Yao, Z.; Wu, Y.; Seto, M. K. C.; Leung, K. K.; Wells, J. A.
Show abstract
Tumor reliance on antioxidant defenses creates a vulnerability to ferroptosis, yet strategies to therapeutically disable these systems remain limited. Here, we identify targeted degradation of the selenium uptake receptor LRP8 as an effective approach to decrease the abundance of the ferroptosis-protective enzyme glutathione peroxidase 4 (GPX4). Using bispecific cytokine receptor-targeting chimeras (KineTACs) that couple LRP8 to cytokine receptor internalization pathways, we selectively direct LRP8 to the lysosome for degradation. LRP8 degradation reduces the abundance of several selenoproteins, including GPX4, lowering the cellular threshold for lipid peroxidation and sensitizing cancer cells to ferroptosis. These findings establish receptor-mediated selenium uptake as a critical, targetable node in ferroptosis resistance and demonstrate that extracellular protein degradation can be leveraged to reprogram intracellular translational dependencies in cancer cells. More broadly, this work provides a framework for exploiting nutrient acquisition pathways to overcome therapy resistance.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.